← Leaderboards
Ugur Ozerdem
La Jolla Inst For Molecular Medicine
$768,238
Attributed
$768,238
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $271.8K · FY2006–08$500K$375K$250K$125K$0
'06
'07
'08
Funding mix
By agency
NIH$768,238 · 3
By mechanism
R21$478,038 · 1
R03$290,200 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Proteoglycan”
- Pyong Woo Park · Baylor College Of Medicine$19,694,248
- Jeffrey D Esko · University Of California San Diego$19,208,444
- Ravinder R Regatte · New York University School Of Medicine$17,649,381
- Renato V. Iozzo · Thomas Jefferson University$15,775,453
- Yu Yamaguchi · Sanford Burnham Prebys Medical Discovery Institute$12,492,066
- David E Birk · Thomas Jefferson University$11,986,022
Research focus
ProteoglycanCell ProliferationPathologic NeovascularizationMalignant NeoplasmsNg2 AntigenNumbersInterstitialCutaneous MelanomaInvestmentsLiquid SubstanceEndothelial CellsNeovascularizationEndotheliumEnhanced Green Fluorescent ProteinHypertensionInvestigationBone MarrowIntercellular FluidCspg4 GeneCellsIn VitroLeadAngiogenesisNeovascular
Grant awards (6)
Improving transcapillary transport by reducing interstitial fluid pressure$94,700
R03 · FY2008 · EB · contact PI
Targeting Vasculogenesis and Interstitial Hypertension in Neurofibromatosis Type1$116,708
R21 · FY2007 · HD · contact PI
Targeting Vasculogenesis and Interstitial Hypertension in Neurofibromatosis Type1$89,546
R21 · FY2007 · HD · contact PI
Targeting Vasculogenesis and Interstitial Hypertension in Neurofibromatosis Type1$271,784
R21 · FY2006 · HD · contact PI
PERICYTES IN ANGIOGENESIS IN NEUROFIBROMATOSIS TYPE 1$97,750
R03 · FY2004 · HD
PERICYTES IN ANGIOGENESIS IN NEUROFIBROMATOSIS TYPE 1$97,750
R03 · FY2003 · HD